Remission of Food Addiction Does Not Induce Cross-Addiction after Sleeve Gastrectomy and Gastric Bypass: A Prospective Cohort Study.

Behavior, Addictive Female Food Addiction / surgery Gastrectomy Gastric Bypass Germany Humans Male Obesity / surgery Prospective Studies
Addiction Addiction remission Addiction transfer Alcohol Cross-addiction Drug Exercise Food Food addiction Gastric bypass Nicotine Sleeve gastrectomy Sport

Journal

Obesity facts
ISSN: 1662-4033
Titre abrégé: Obes Facts
Pays: Switzerland
ID NLM: 101469429

Informations de publication

Date de publication:
2020
Historique:
received: 10 12 2019
accepted: 25 02 2020
pubmed: 6 5 2020
medline: 23 4 2021
entrez: 6 5 2020
Statut: ppublish

Résumé

The hypothesis of "cross-addiction" has never been validated, and numerous aspects speak against it. To compare the differences between sleeve gastrectomy (SG) and gastric bypass (GB) procedures concerning cross-addiction. Center for maximum care in Germany. We performed a prospective analysis of patients undergoing SG or GB as the first surgical treatment for severe obesity. All patients completed validated questionnaires to evaluate food intake (Yale Food Addiction Scale, YFAS), alcohol intake (Alcohol Use Disorders Identification Test), nicotine use (Fagerstrom Test for Nicotine Dependence), exercise (Exercise Addiction Inventory), drug addiction (20-item Drug Abuse Screening Test), and Internet use disorder (Internet Addiction Test) before the operation (T0) and 6 (T6) and 24 (T24) months postoperatively (ClinicalTrials.gov identifier: NCT02757716). One hundred thirteen patients underwent SG (n = 68) or GB (n = 45). At the follow-up, 61% completed the questionnaires at T6 and 44% at T24. In the YFAS, the percentage of patients diagnosed with food addiction decreased from 69 to 10%, and the mean symptom count decreased from 3.52 ± 1.95 to 1.26 ± 0.99 at T24 (p < 0.0001); these values did not differ between the surgical groups (p = 0.784). No significant evidence of cross-addiction was observed for use of alcohol, nicotine, drugs, the Internet, or exercise in either surgical group. The percentage of patients with moderate nicotine dependence increased in the SG group (+8.9%) at T24, but this was not significant. In this single-center cohort study, surgery for obesity caused significant addiction remission regarding food but without inducing cross-addiction after 2 years. Importantly, no significant differences were seen between the SG and GB procedures.

Sections du résumé

BACKGROUND
The hypothesis of "cross-addiction" has never been validated, and numerous aspects speak against it.
OBJECTIVES
To compare the differences between sleeve gastrectomy (SG) and gastric bypass (GB) procedures concerning cross-addiction.
SETTING
Center for maximum care in Germany.
METHODS
We performed a prospective analysis of patients undergoing SG or GB as the first surgical treatment for severe obesity. All patients completed validated questionnaires to evaluate food intake (Yale Food Addiction Scale, YFAS), alcohol intake (Alcohol Use Disorders Identification Test), nicotine use (Fagerstrom Test for Nicotine Dependence), exercise (Exercise Addiction Inventory), drug addiction (20-item Drug Abuse Screening Test), and Internet use disorder (Internet Addiction Test) before the operation (T0) and 6 (T6) and 24 (T24) months postoperatively (ClinicalTrials.gov identifier: NCT02757716).
RESULTS
One hundred thirteen patients underwent SG (n = 68) or GB (n = 45). At the follow-up, 61% completed the questionnaires at T6 and 44% at T24. In the YFAS, the percentage of patients diagnosed with food addiction decreased from 69 to 10%, and the mean symptom count decreased from 3.52 ± 1.95 to 1.26 ± 0.99 at T24 (p < 0.0001); these values did not differ between the surgical groups (p = 0.784). No significant evidence of cross-addiction was observed for use of alcohol, nicotine, drugs, the Internet, or exercise in either surgical group. The percentage of patients with moderate nicotine dependence increased in the SG group (+8.9%) at T24, but this was not significant.
CONCLUSION
In this single-center cohort study, surgery for obesity caused significant addiction remission regarding food but without inducing cross-addiction after 2 years. Importantly, no significant differences were seen between the SG and GB procedures.

Identifiants

DOI: 10.1159/000506838 PMID: 32369811 PMC: PMC7445574
pubmed: 32369811
pii: 000506838
doi: 10.1159/000506838
pmc: PMC7445574
doi:

Banques de données

ClinicalTrials.gov
['NCT02757716']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

307-320

Informations de copyright

© 2020 The Author(s) Published by S. Karger AG, Basel.

Références

Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Surg Obes Relat Dis. 2017 Feb;13(2):220-226
pubmed: 27771313
JAMA. 2018 Jan 16;319(3):291-301
pubmed: 29340680
Gastroenterology. 2019 May;156(6):1627-1641.e1
pubmed: 30742833
Nat Rev Gastroenterol Hepatol. 2018 Oct;15(10):606-624
pubmed: 30181611
Surg Obes Relat Dis. 2018 Aug;14(8):1173-1181
pubmed: 29858129
Nat Neurosci. 2005 Nov;8(11):1445-9
pubmed: 16251986
Riv Psichiatr. 2019 May-Jun;54(3):127-130
pubmed: 31282493
Wien Klin Wochenschr. 2019 May;131(Suppl 1):67-70
pubmed: 30980165
Obes Facts. 2011;4 Suppl 1:39-41
pubmed: 22027289
Obes Surg. 2019 Aug;29(8):2700-2703
pubmed: 31147822
Nicotine Tob Res. 2015 Jul;17(7):855-61
pubmed: 25481918
Addict Behav. 2008 Aug;33(8):1086-9
pubmed: 18502052
Obesity (Silver Spring). 2014 Aug;22(8):1792-8
pubmed: 24852693
Surg Obes Relat Dis. 2016 Dec;12(10):1847-1855
pubmed: 27317606
Obes Rev. 2017 Dec;18(12):1386-1397
pubmed: 28948684
Compr Psychiatry. 2017 Feb;73:97-104
pubmed: 27930952
Eur Eat Disord Rev. 2018 Nov;26(6):585-596
pubmed: 30094889
Eur Eat Disord Rev. 2012 Sep;20(5):419-22
pubmed: 22761046
Br J Sports Med. 2005 Jun;39(6):e30
pubmed: 15911594
Surg Obes Relat Dis. 2017 Mar;13(3):392-398
pubmed: 27913121
Eat Weight Disord. 2019 Dec;24(6):1031-1039
pubmed: 30850958
Addict Behav. 2019 Mar;90:421-427
pubmed: 30553156
Surg Obes Relat Dis. 2015 Jan-Feb;11(1):14-8
pubmed: 25443061
Obes Surg. 2018 Oct;28(10):3304-3305
pubmed: 30054875
Biol Psychiatry. 2013 May 1;73(9):811-8
pubmed: 23374642
Curr Psychiatry Rep. 2019 Aug 13;21(9):85
pubmed: 31410716
Lancet Gastroenterol Hepatol. 2017 Oct;2(10):747-756
pubmed: 28844808
Psychiatry Res. 2016 Oct 30;244:159-64
pubmed: 27479107
Psychiatry Res. 2012 Apr 30;196(2-3):296-301
pubmed: 22386568
JAMA. 2012 Jun 20;307(23):2516-25
pubmed: 22710289
Brain Behav Immun. 2019 Mar;77:16-24
pubmed: 30468859
Drug Alcohol Depend. 2017 Oct 1;179:229-239
pubmed: 28806640
PLoS One. 2019 Feb 4;14(2):e0209442
pubmed: 30716098
Surg Obes Relat Dis. 2017 Aug;13(8):1392-1402
pubmed: 28528115
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2015 Dec;50(6):310-24
pubmed: 26964292

Auteurs

Sonja Chiappetta (S)

Department of Obesity and Metabolic Surgery, Ospedale Evangelico Betania, Naples, Italy, drschiappetta@gmail.com.
Department of Obesity and Metabolic Surgery, Sana Klinikum Offenbach, Offenbach am Main, Germany, drschiappetta@gmail.com.

Christine Stier (C)

Department of Obesity and Metabolic Surgery, Sana Klinikum Offenbach, Offenbach am Main, Germany.
Obesity Center NRW, Sana Kliniken Germany, Hürth, Germany.

Mohamed Ajan Hadid (MA)

Department of Obesity and Metabolic Surgery, Sana Klinikum Offenbach, Offenbach am Main, Germany.

Nina Malo (N)

Department of Obesity and Metabolic Surgery, Sana Klinikum Offenbach, Offenbach am Main, Germany.

Sophia Theodoridou (S)

Department of Obesity and Metabolic Surgery, Sana Klinikum Offenbach, Offenbach am Main, Germany.

Rudolf Weiner (R)

Department of Obesity and Metabolic Surgery, Sana Klinikum Offenbach, Offenbach am Main, Germany.

Sylvia Weiner (S)

Department of Obesity and Metabolic Surgery, Krankenhaus Nordwest, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Comportement impulsif › Comportement compulsif › Comportement toxicomaniaque › Remission of Food Addiction Does Not Induce...
questionsmedicales.fr › Troubles mentaux › Troubles de l'alimentation › Addiction à la nourriture › Remission of Food Addiction Does Not Induce...
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de chirurgie digestive › Gastrectomie › Remission of Food Addiction Does Not Induce...
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de chirurgie digestive › Gastroentérostomie › Dérivation gastrique › Remission of Food Addiction Does Not Induce...
questionsmedicales.fr › Régions géographiques › Europe › Allemagne › Remission of Food Addiction Does Not Induce...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Remission of Food Addiction Does Not Induce...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Remission of Food Addiction Does Not Induce...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Remission of Food Addiction Does Not Induce...